NCT03139435View on ClinicalTrials.gov

Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 11, 2017

Primary Completion Date

December 12, 2018

Study Completion Date

January 11, 2019

Conditions
Peripheral NeuropathyStage 0 Breast CancerStage I Breast CancerStage IA Breast CancerStage IB Breast CancerStage II Breast CancerStage IIA Breast CancerStage IIB Breast CancerStage III Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast CancerStage IV Breast Cancer
Interventions
PROCEDURE

Biopsy

Undergo skin biopsy

OTHER

Questionnaire Administration

Ancillary studies

DIAGNOSTIC_TEST

Ultrasound Tomography

Undergo peripheral nerve ultrasound

Trial Locations (1)

27157

Comprehensive Cancer Center of Wake Forest University, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT03139435 - Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer | Biotech Hunter | Biotech Hunter